• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Are biotech SPACs back? Cancer-focused Apollomics next to take blank-check route

cafead

Administrator
Staff member
  • cafead   Sep 15, 2022 at 11:42: PM
via Are we witnessing the return of biotech SPACs? It's worth considering as Apollomics merges with Maxpro Capital Acquisition Corp.—the second such transaction in recent weeks.

article source
 

<